NDC product
Vicks DayQuil HIGH BLOOD PRESSURE COLD and FLU
NDC 69423-803 · The Procter & Gamble Manufacturing Company
Key facts
| Product NDC | 69423-803 |
|---|---|
| Proprietary name | Vicks DayQuil |
| Nonproprietary name | Acetaminophen, Dextromethorphan HBr |
| Substances | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | The Procter & Gamble Manufacturing Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| Marketing start | Jul 11, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: